{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:32:21Z","timestamp":1773797541648,"version":"3.50.1"},"reference-count":20,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"funder":[{"name":"Grants from Jiangsu Province 333 High Level Talent Training Project, Lianyungang Ageing Health Research Project"},{"name":"Lianyungang Traditional Chinese Medicine Administration Project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Background: Treatment strategies differ in acute ischemic stroke (AIS) patients with and without non-valvular atrial fibrillation (NVAF): AIS with NVAF requires anticoagulation (e.g. warfarin\/direct oral anticoagulants) for secondary prevention, while AIS without NVAF relies on antiplatelet therapy (e.g. aspirin\/clopidogrel). It remains unclear whether coagulation function indices can be used to distinguish between the two conditions. Methods: In this retrospective study, AIS patients with NVAF (AIS with NVAF group, n=43) and without NVAF (AIS without NVAF group, n = 90) admitted to our hospital were enrolled for final analysis. The levels of coagulation function indices, including d-dimer (DD), activated partial thromboplastin time (APTT), prothrombin time (PT), international normalised ratio (INR), thrombin time (TT), and fibrinogen, were tested before or on admission and compared between the two groups. Results: Compared with AIS without NVAF group, DD, PT, and INR were increased and APTT was decreased in AIS with NVAF group (P&amp;lt; 0.05), whereas, there were no significantly statistical differences of TT and fibrinogen (P&amp;gt; 0.05); next, the AUC in distinguishing between AIS with and without NVAF were 0.753, 0.761, 0.775, and 0.770 for DD, APTT, PT, and INR, respectively (P&amp;lt; 0.05). Conclusions: DD, APTT, PT and INR demonstrated moderate diagnostic value (AUC 0.75-0.78) for distinguishing AIS with NVAF.<\/jats:p>","DOI":"10.5937\/jomb0-60388","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T08:01:37Z","timestamp":1756195297000},"page":"594-600","source":"Crossref","is-referenced-by-count":0,"title":["Values of D-dimer, APTT, PT and INR in distinguishing between acute ischemic stroke patients with and without non-valvular atrial fibrillation"],"prefix":"10.5937","volume":"45","author":[{"given":"Qing","family":"Du","sequence":"first","affiliation":[{"name":"Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, Department of Neurology, Lianyungang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, Department of Laboratory, Lianyungang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Song","sequence":"additional","affiliation":[{"name":"Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, Department of Geriatrics, Lianyungang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Jiang","sequence":"additional","affiliation":[{"name":"Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, Department of Geriatrics, Lianyungang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiming","family":"Zheng","sequence":"additional","affiliation":[{"name":"Jiangsu Province Hospital of Chinese Medicine, Department of Geriatrics, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuezhan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, Department of Geriatrics, Lianyungang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","unstructured":"Collaborators GBDSRF Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology 2024; 23(10): 973-1003;"},{"key":"ref2","unstructured":"Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. The Lancet Neurology 2019; 18(4): 394-405;"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Le Goff L, Demuth S, Fickl A, Muresan L. Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation. Arq Neuropsiquiatr 2023; 81(8): 712-9;","DOI":"10.1055\/s-0043-1771167"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Duarte RCF, Rios DRA, Figueiredo EL, Caiaffa JRS, Silveira FR, Lanna R, et al. Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban. J Thromb Thrombolysis 2021; 51(1): 47-57;","DOI":"10.1007\/s11239-020-02126-3"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Tayal D, Jain P Goswami B. D-dimer - a multifaceted molecule. Horm Mol Biol Clin Investig. 2024; 45(2): 75-84;","DOI":"10.1515\/hmbci-2022-0093"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kida K, Nabeta T, Ishida M, Shiono T, Suzuki N, Doi S, et al. D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban. Journal of cardiology 2022; 79(6): 759-67;","DOI":"10.1016\/j.jjcc.2022.01.005"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Almorad A, Ohanyan A, Pintea Bentea G, Wielandts JY, El Haddad M, Lycke M, et al. D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation. Heart 2021; 107(3): 195-200;","DOI":"10.1136\/heartjnl-2020-317612"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Shen Z, Chen D, Cheng H, Tan F Yan J, Deng H, et al. N-terminal pro-B-type natriuretic peptide and D-dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation. Clin Cardiol 2023; 46(1): 41-8;","DOI":"10.1002\/clc.23933"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Shi Y, Xuan C, Ji W, Wang F Huang J, Li L, et al. Combination of platelet-to-lymphocyte ratio and D-dimer for the identification of cardiogenic cerebral embolism in non-valvular atrial fibrillation. Front Neurol 2023; 14: 1069261;","DOI":"10.3389\/fneur.2023.1069261"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2024; 149(1): e1-e156;","DOI":"10.1161\/CIR.0000000000001207"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Liu L, Xie P , Zhu P , Zhuo W, Xu A. Role of the score for the targeting of atrial fibrillation (STAF) combined with D-dimer in screening ischemic stroke patients with atrial fibrillation. J Med Biochem 2024; 43(1): 57-62;","DOI":"10.5937\/jomb0-44255"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Uchiyama S, Suzuki-Inoue K, Wada H, Okada Y Hirano T, Nagao T, et al. Soluble C-type lectin-like receptor 2 in stroke (CLECSTRO) study: protocol of a multicentre, prospective cohort of a novel platelet activation marker in acute ischaemic stroke and transient ischaemic attack. BMJ open 2023; 13(9): e073708;","DOI":"10.1136\/bmjopen-2023-073708"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Shah IK, Merfeld JM, Chun J, Tak T Pathophysiology and Management of Pulmonary Embolism. Int J Angiol 2022; 31(3): 143-9;","DOI":"10.1055\/s-0042-1756204"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Helin T, Palviainen M, Lemponen M, Maaninka K, Siljander P Joutsi-Korhonen L. Increased circulating platelet-derived extracellular vesicles in severe COVID-19 disease Platelets. 2024; 35(1): 2313362;","DOI":"10.1080\/09537104.2024.2313362"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Abenavoli L, Aquila I, Sacco MA, Procopio AC, Cinaglia P Zanza C, et al. Liver injury associated with high value of D-dimer plasmatic level in COVID-19 patients. Minerva Gastroenterol (Torino) 2023; 69(1): 141-8;","DOI":"10.23736\/S2724-5985.22.03189-8"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Huang H, Qu T, Hu M, Chen Z, Fan K, Mo X. APTT critical value establishment in four different reagent\/instrument systems based on single factor deficiencies. Ann Hematol 2024; 103(8): 3219-27;","DOI":"10.1007\/s00277-024-05718-8"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Neves G, Lee J, Bueso T, Montalvan V, Iskandir M, Shurmur S, et al. Intravenous thrombolysis for the management of acute ischemic stroke in patients therapeutically anticoagulated with heparin: A review. Clin Neurol Neurosurg 2021; 200: 106382;","DOI":"10.1016\/j.clineuro.2020.106382"},{"key":"ref18","unstructured":"Senst B, Tadi P Basit H, Jan A. Hypercoagulability. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Prasanna Tadi declares no relevant financial relationships with ineligible companies. Disclosure: Hajira Basit declares no relevant financial relationships with ineligible companies. Disclosure: Arif Jan declares no relevant financial relationships with ineligible companies. 2025;"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Wang SS, Xu H, Ge AQ, Yang KL, He Q, Ge JW. Bombyx batryticatus extract activates coagulation factor to promote angiogenesis in rats with cerebral ischemia\/reperfusion injury. Journal of ethnopharmacology 2024; 319(Pt 1): 117081;","DOI":"10.1016\/j.jep.2023.117081"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Martins GL, Duarte RCF Vieira ELM, Rocha NP Figueiredo EL, Silveira FR, et al. Evaluation of New Potential Inflammatory Markers in Patients with Nonvalvular Atrial Fibrillation. Int J Mol Sci 2023; 24(4);","DOI":"10.3390\/ijms24043326"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Vrednosti D-dimera, APTT-a, PT -a i INR -a u razlikovanju pacijenata sa akutnim ishemijskim mo\u017edanim udarom sa i bez nevalvularne atrijalne fibrilacije"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/60388\/28545","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582603594D.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:16:41Z","timestamp":1773782201000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582603594D"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-60388","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}